Truxima Hits 20% Share For Teva

Rheumatoid Arthritis Indication Helps Rituximab Biosimilar Gain Ground In US

 
• By David Wallace
Cake slice
Teva’s rituximab biosimilar captures a fifth of the US market • Source: Shutterstock

More from Biosimilars

More from Products